Pre-Prescribing Suicide Risk Assessment

A Clinical Workflow Guide

There is a quiet but important shift happening in mental health care. The expectation is no longer just that we ask about suicidality, it is that we assess it, document it, and use it to guide clinical decision-making, especially before prescribing.

For clinicians, this is not new in principle. But in practice, it can be hard to do consistently in a busy outpatient setting. Time is limited. Information is fragmented. And too often, suicide risk is reduced to a single question or checkbox.

That approach is no longer enough.

This guide walks through a practical, real-world workflow for assessing suicide risk before prescribing, how tools like the Columbia-Suicide Severity Rating Scale fit in, and where a more comprehensive, structured assessment adds meaningful clinical value.

Why Suicide Risk Assessment Before Prescribing Matters

Prescribing decisions, especially for antidepressants, stimulants, and other psychotropic medications, don’t happen in a vacuum.

They sit within a broader clinical picture that should include:

• Current and past suicidal ideation
• History of attempts or preparatory behaviors
• Co-occurring conditions (e.g., substance use, bipolar disorder)
• Acute stressors and psychosocial context

From a clinical standpoint, this is about safety and good care.

From a systems standpoint, expectations are rising:

• Documentation of suicide risk is increasingly scrutinized
• Treatment decisions are expected to be clearly supported in the chart
• Risk monitoring over time is becoming part of quality measurement

Suicide risk assessment is not a separate task; it is foundational to prescribing.

Step 1: Start with a Standardized Tool (and Use It Well)

The C-SSRS is widely used for a reason. It provides a structured way to assess:

• Severity of ideation
• Presence of a plan
• Intent
• Past suicidal behavior

Used properly, it brings consistency and clarity to an area that can otherwise feel subjective.

The C-SSRS:

✔️ Identifies and stratifies suicide risk
✔️ Creates a shared language across providers
✔️ Supports documentation

It does not:

❌ Fully explain why the risk is present
❌ Capture the broader diagnostic context
❌ Replace clinical judgment or differential diagnosis

In other words, it is a critical component, but not the full picture.

Step 2: Expand Beyond the Single Lens

Suicidal ideation rarely exists in isolation.

A patient endorsing SI may also be experiencing:

• Major depressive disorder
• Bipolar disorder (including mixed features)
• PTSD or trauma-related symptoms
• Substance use disorders
• Severe anxiety or panic
• Personality-related patterns
• Sleep disruption or cognitive overload

Without systematically assessing these areas, clinicians are often left connecting the dots in real time.

This is where many workflows break down.

A more comprehensive approach allows you to:

• Understand drivers of suicidality, not just presence
• Identify missed or competing diagnoses
• Clarify treatment targets before prescribing

This is especially important when considering medications that:

• May take time to work
• May initially increase activation
• Require monitoring for safety and effectiveness

Step 3: Integrate Findings into Prescribing Decisions

A strong pre-prescribing workflow doesn’t stop at identifying risk, it uses that information.

For example:

• Passive SI + depressive symptoms, no plan or intent → May proceed with outpatient treatment, with monitoring and follow-up
• Active SI with plan or intent → Requires immediate safety planning, possible higher level of care
• SI with possible bipolar features → Changes medication selection and sequencing
• SI with substance use → Points toward integrated or prioritized SUD treatment

The key is that suicide risk is contextualized, not treated as a standalone variable.

Step 4: Document in a Way That Tells the Story

Good documentation is not about checking boxes, it’s about making your thinking visible.

A strong note should clearly reflect:

• What was assessed (e.g., C-SSRS findings)
• How risk was stratified
• What contributing factors were identified
• How this informed the treatment plan

This is increasingly important for:

• Continuity of care across providers
• Supervisory or team-based settings
• Payor and regulatory expectations

When documentation shows a clear line from assessment → interpretation → decision, it becomes both clinically useful and defensible.

Step 5: Reassess Over Time (Not Just Once)

Suicide risk is dynamic.

A one-time assessment at intake is not sufficient, especially when:

• Medications are initiated or adjusted
• Life circumstances change
• Symptoms evolve

A strong workflow includes: 

• Planned reassessment intervals
• Trigger-based reassessments (e.g., symptom worsening)
• Longitudinal tracking of risk and related symptoms

This is where many practices are heading: from static screening → to ongoing, measurement-informed care.

Where Comprehensive Assessment Fits In

Standardized tools like the C-SSRS are essential. They create structure and consistency.

But they are most powerful when embedded within a broader, comprehensive assessment framework that:

• Screens across diagnostic categories
• Uses validated instruments, not one-off questions
• Connects symptoms to clinical decision-making
• Tracks change over time

This is the gap many clinicians feel in day-to-day practice:

• Not enough time to assess everything thoroughly
• Too much reliance on a few isolated scales
• Pressure to make prescribing decisions quickly

A structured, comprehensive approach helps bridge that gap.

It allows clinicians to:

☑️ Spend more time understanding the patient
☑️ Rely less on memory or mental checklists
☑️ Make more confident, informed decisions

Raising the Bar Without Slowing Clinicians Down

The goal is not to add more work.

It is to replace fragmented workflows with integrated ones. When suicide risk assessment is:

• Structured
• Contextualized
• Connected to diagnosis and treatment

…it become a meaningful part of how we understand and care for patients.

At its best, pre-prescribing suicide risk assessment does two things at once: It keeps patients safer, and it helps clinicians make better decisions with more confidence.

That’s the standard mental health care is moving toward. And it’s one worth building toward thoughtfully.